MEGHAN DICKERSON: Open Payments
NPI 1750770541 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,073 in 49 payments from 18 companies in 2025. Trend: 2023 $989 · 2024 $1,467 · 2025 $1,073
Food & beverage: $1,073
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 5 | $176 |
| UCB, Inc. | 6 | $158 |
| Janssen Biotech, Inc. | 9 | $146 |
| Novartis Pharmaceuticals Corporation | 3 | $81 |
| Amgen Inc. | 3 | $58 |
| ABBVIE INC. | 3 | $56 |
| Galderma Laboratories, L.P. | 3 | $56 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| Lilly USA, LLC | 2 | $46 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $38 |
Products named: VTAMA, Bimzelx, TREMFYA, COSENTYX, OTEZLA, SKYRIZI, NEMLUVIO, Sotyktu.
Industry payments across AZ — which companies pay providers there.
